Auvi-q Injection, Solution
Product Images NDC 71872-7173

20 FDA label images from Medical Purchasing Solutions, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Auvi-q (NDC 71872-7173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7173-1 Pdp (7173)

71872-7173-1 Pdp (7173)
Label for Auvi-Q epinephrine injection USP 0.3 mg prefilled auto-injector. The label states it is for allergic emergencies in patients over 66 lbs, single-use only. It includes storage instructions, contents per mL, manufacturer info (kaleo, inc., Richmond, VA, origin Germany), and repackager Medical Purchasing Solutions, Scottsdale, AZ.*
FDA Label Image

Chemical Structure (Auvi Q 01)

Chemical Structure (Auvi Q 01)
Chemical structure of epinephrine, the active ingredient in Auvi-Q. The diagram shows the molecular arrangement including a benzene ring with hydroxyl groups, a catechol group, and an amine side chain.*
FDA Label Image

Figure A (Auvi Q 02)

Figure A (Auvi Q 02)
An instructional diagram showing two components of the Auvi-Q epinephrine injection device: the main injection device with labeled features including speaker, LED lights, viewing window, red safety guard at the needle end, and black base; and the outer protective case with a directional arrow on the front.*
FDA Label Image

Figure B (Auvi Q 03)

Figure B (Auvi Q 03)
An instructional illustration showing hands manipulating an Auvi-Q autoinjector device by pushing yellow arrows on the device's sides, likely indicating steps to remove or prepare the injection for use. The image highlights the device's interaction points with arrows indicating upward and downward movements.*
FDA Label Image

Figure C (Auvi Q 04)

Figure C (Auvi Q 04)
An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device positioned above a human thigh. Arrows indicate the direction to press the device firmly against the thigh to administer the intramuscular injection.*
FDA Label Image

Figure D (Auvi Q 05)

Figure D (Auvi Q 05)
An instructional illustration showing a person holding the Auvi-Q epinephrine injection device with an arrow pointing to the side of the hand. Next to this, a stopwatch graphic displays a yellow highlighted segment indicating 2 seconds, emphasizing the recommended injection duration.*
FDA Label Image

Figure E (Auvi Q 06)

Figure E (Auvi Q 06)
An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device against a blue thigh, indicating the injection site. Next to it is a stopwatch graphic emphasizing a 2-second count, likely related to the injection duration or timing instructions.*
FDA Label Image

Figure A1 (Auvi Q 07)

Figure A1 (Auvi Q 07)
An instructional diagram of the Auvi-Q Trainer device, an epinephrine injection simulation for practice use. The illustration labels the outer case, device housing, speaker, LEDs, base, and safety guard, showing how the trainer is stored and operated. The trainer is marked for practice use only and is not a real injection device.*
FDA Label Image

Figure A2 (Auvi Q 08)

Figure A2 (Auvi Q 08)
Auvi-Q Trainer injection, solution in a black and white rectangular plastic case labeled "TRAINER." Designed for intramuscular use, this is a training device version of the epinephrine injection product by Medical Purchasing Solutions, LLC. Strength and vial count are not shown on this case label.*
FDA Label Image

Figure A3 (Auvi Q 09)

Figure A3 (Auvi Q 09)
Packaging label for Auvi-Q 0.3 mg epinephrine injection, solution in autoinjector form by Medical Purchasing Solutions, LLC. The label features administration instructions and dosage information for intramuscular use and highlights the product as an epinephrine autoinjector for emergency treatment.*
FDA Label Image

Figure A4 (Auvi Q 10)

Figure A4 (Auvi Q 10)
The image shows the front and back panels of the Auvi-Q 0.3 mg epinephrine injection solution intramuscular auto-injector packaging. The front blue panel displays the brand name Auvi-Q with strength 0.3 mg/.3 mL, the active ingredient epinephrine, and a pull-tab instruction. The white back panel includes administration instructions, a speaker icon, and dosage usage text. The labeler is Medical Purchasing Solutions, LLC.*
FDA Label Image

Figure A5 (Auvi Q 11)

Figure A5 (Auvi Q 11)
Auvi-Q 0.3 mg epinephrine injection, solution, auto-injector packaging with detailed usage instructions. Front label shows proprietary name Auvi-Q, generic name epinephrine, dosage strength 0.3 mg/0.3 mL, intramuscular injection route, and labeler Medical Purchasing Solutions, LLC. Reverse side includes step-by-step instructions and warnings for use.*
FDA Label Image

Figure B (Auvi Q 12)

Figure B (Auvi Q 12)
An instructional illustration showing hands holding an Auvi-Q epinephrine injection device. The image depicts directional arrows indicating how to operate or activate the device, focusing on pressing or sliding mechanisms for intramuscular injection use.*
FDA Label Image

Figure C (Auvi Q 13)

Figure C (Auvi Q 13)
An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device. The image demonstrates pressing the device firmly against the thigh, with arrows indicating the direction to press for intramuscular injection.*
FDA Label Image

Figure D (Auvi Q 14)

Figure D (Auvi Q 14)
An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device against the outer thigh, indicating the injection position. Next to it is a stopwatch graphic timing 2 seconds, suggesting how long to hold the device in place after administration.*
FDA Label Image

Figure E (Auvi Q 15)

Figure E (Auvi Q 15)
An instructional illustration showing hands holding an Auvi-Q epinephrine injection device over a blue circular target on a leg, demonstrating the proper intramuscular injection site and technique for administration.*
FDA Label Image

Figure F (Auvi Q 16)

Figure F (Auvi Q 16)
An instructional illustration showing a hand holding the Auvi-Q injection device with arrows indicating to not hold the black base while inserting the red safety guard, demonstrating proper handling of the epinephrine autoinjector.*
FDA Label Image

Figure G (Auvi Q 17)

Figure G (Auvi Q 17)
An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device. The image demonstrates how to operate the device by pushing down with the thumb while pressing with the index finger, with directional arrows indicating movement. The device is shown upright with a black arrow on its surface.*
FDA Label Image

0.3 mg Outer Case Label (Auvi Q 19)

0.3 mg Outer Case Label (Auvi Q 19)
Auvi-Q 0.3 mg epinephrine injection USP auto-injector label. The label includes storage instructions, use for allergic emergencies in patients over 66 lb, and manufacturer information for Kaleo. It emphasizes single-use injection with instructions inside the device and cautions about storage temperature and inspection before use.*
FDA Label Image

0.3 mg Device Label (Auvi Q 20)

0.3 mg Device Label (Auvi Q 20)
Auvi-Q 0.3 mg epinephrine injection, USP auto-injector label for allergic emergencies. The label provides step-by-step usage instructions with illustrations: pull the red safety guard, place the black end against the outer thigh, and push firmly for 2 seconds. Includes warnings to seek medical attention and for single-use injection. Manufactured by Kaleo, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.